DMSO Cell Cryopreservation Medium Market Report On Size, Share, Scope And Forecast 2024-2031 By Top Research Firm

DMSO Cell Cryopreservation Medium Market Report On Size, Share, Scope And Forecast 2024-2031 By Top Research Firm
DMSO Cell Cryopreservation Medium Market
DMSO Cell Cryopreservation Medium Market is expected to expand with a CAGR of 9.11% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global DMSO Cell Cryopreservation Medium Market – (By Type (Stem Cell, CHO Cells, T Cells, Others), By Application (Hospital, Research Institute, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global DMSO Cell Cryopreservation Medium Market is expected to expand with a CAGR of 9.11% during the forecast period of 2024-2031.


DMSO is a Cryopreservation that involves putting cells in liquid nitrogen or another extremely cold environment to halt their metabolic rate and protect them from deterioration. By lowering their metabolic activity, maintaining their viability, and freezing them at low temperatures, cryopreservation aims to preserve biological materials by avoiding the formation of ice crystals. Extremely low temperatures cause little ice crystals to develop. These can potentially disrupt cell membranes in cells and tissues, leading to cell death. The growing fascination with cell-based treatments and regenerative medicine is driving the demand for cell-freezing mediums. Increases in R&D spending in the biotechnology and biopharmaceutical industries are fueling the expansion of these markets. However, the cell cryopreservation market is anticipated to be held back by the availability of alternative methods for cell cryopreservation.


Request for Sample Pages:


List of Prominent Players in the DMSO Cell Cryopreservation Medium Market:

  • Thermo Fisher Scientific
  • Biolife Solutions
  • Kitazato
  • Sartorius AG
  • Shanghai Biyuntian Biotechnology Co., Ltd.
  • Beijing Baiolaibo Technology Co., Ltd.
  • HiMedia
  • Biological Industries
  • Other Market Players


Market Dynamics:



The growing demand for the DMSO cell cryopreservation medium market is fueled by rising chronic diseases and novel viral infections. Researchers at the postdoctoral level, clinical research fellows, and doctorate students from universities across the globe are receiving funding to further their studies in stem cell research. The expansion of this sector is largely attributable to the numerous new government programs that fund pharmaceutical and biopharmaceutical research. The rising need for customized medications, the proliferation of stem cell research and development initiatives, the number of biobanks, and the frequency of egg-freezing cycles are all projected to propel the cell cryopreservation market to new levels.



The prime challenges are insufficient technological knowledge, a shortage of competent individuals, and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the DMSO cell cryopreservation medium market. The technique is technically hard due to the subtleties involved in accurately managing the freezing and thawing rates, selecting effective cryoprotectants, and adapting protocols for varied cell types. Various cell types and their specific cryopreservation needs make process standardization a challenging and daunting. Researchers and organizations that want to use cryopreservation technology have it tough because of how complicated it is and how much skilled workers are needed to make it all work. Due to the COVID-19 pandemic, which has affected the worldwide market and forced the closure of numerous factories to protect their personnel from contracting the virus, the expansion of the industry may be hindered.


Regional Trends:

The North American DMSO cell cryopreservation medium market is anticipated to record a large market share in revenue. It is projected to grow at a high CAGR in the near future because of a well-developed healthcare system, a prosperous economy, influential individuals, and well-laid supply lines. Furthermore, the biopharmaceutical business is in a mad dash to discover cutting-edge, effective treatments due to the increasing number of ailments and the population’s average age. In addition, the Asia Pacific region experienced significant market dominance as a result of the growing need for more economical solutions and the emphasis on minimizing machinery failures.


Curious About This Latest Version Of The Report? Enquiry Before Buying:


Recent Developments:


  • In June 2023, BioLife Solutions, Inc. has introduced a new controlled-rate freezer (CRF) with a larger capacity, in order to expand its existing CRF product range, which now consists of three different form factors. This tabletop freezer meets the important requirement of customers for increased production capacity of cell treatments.


  • In Dec 2019, Sartorius agreed to buy a majority stake in Biological Industries, an Israeli company that develops and makes cell growth media. The owners of the company, Kibbutz Beit Haemek and the private equity fund Fortissimo Capital, sold Sartorius just over half of their shares for about €45 million in cash. 


Segmentation of DMSO Cell Cryopreservation Medium Market-

By Type-

  • Stem Cell
  • CHO Cells
  • T Cells
  • Others

By Application-

  • Hospital
  • Research Institute
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa


For More Customization @

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States